Advertisement · 728 × 90

Posts by Drugs.com

Preview
FDA To Review Whether To Allow More Access To Certain Peptides - Drugs.com MedNews FRIDAY, April 17, 2026 The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by

The FDA is set to review whether restricted peptides can be used in compounded medications, following pressure from patients, telehealth companies, and RFK Jr. Scientists warn that safety data is thin, and many products have skipped clinical trials entirely. #Peptides www.drugs.com/news/fda-rev...

1 day ago 0 0 0 0
Preview
New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes - Drugs.com MedNews THURSDAY, April 16, 2026 New anti-amyloid drugs approved to treat Alzheimer s disease have no clinically meaningful positive effects for patients, a major evide

A Cochrane Review of 17 trials and 20,000+ patients has found that approved Alzheimer's drugs like Leqembi and Kinsula offer no clinically meaningful benefit and may increase the risk of brain swelling and bleeding. Drug makers dispute the findings. #AlzheimersDrugs www.drugs.com/news/new-alz...

2 days ago 1 0 0 0
Preview
New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data - Drugs.com MedNews WEDNESDAY, April 15, 2026 The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity

The FDA approved Eli Lilly's oral obesity drug #Foundayo, but it is requiring long-term studies on heart, liver, and thyroid cancer risks. Experts say no safety problem was found; regulators just want more data on the newer ingredient. www.drugs.com/news/new-wei...

3 days ago 0 0 0 0
Preview
Is Entyvio an immunosuppressant or a biologic? Official answer: Key Takeaways Entyvio (vedolizumab) is a biologic therapy approved for the treatment of ulcerative colitis and...

#Entyvio (vedolizumab) treats ulcerative colitis and Crohn's disease by targeting inflammation directly in the gut, not the whole body. It reduces white blood cells entering the intestines, but a risk of serious infection still exists — always discuss with your doctor.

4 days ago 0 0 0 0
Preview
Long-Term Opioid Prescriptions Fall By About A Quarter - Drugs.com MedNews TUESDAY, April 14, 2026 Long-term opioid prescriptions have declined dramatically in the United States, reflecting progress made against America s opioid epidem

Long-term opioid prescriptions in the US fell 24% between 2015 and 2023, but 4 million Americans remain on them long-term. Researchers say stronger chronic pain guidelines are still needed to reduce overdose risk. #OpioidPrescriptions www.drugs.com/news/long-te...

4 days ago 1 0 0 0
Preview
Topamax for migraines: how long should you take it? Official answer: You can usually stay on Topamax for migraine prevention as long as it is helping and safe for you, but many people use...

#Topamax (topiramate) for migraine prevention is typically used for at least 6–12 months if it's helping. It can take up to 3 months for full effect, and any changes to your dose should always be discussed with your doctor.

5 days ago 0 0 0 0
Preview
Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare - Drugs.com MedNews MONDAY, April 13, 2026 Your genetics might play a role in how well cutting-edge weight loss drugs like Ozempic and Zepbound will work for you, a new study says.

Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare #GLP1Genetics www.drugs.com/news/thinkin...

5 days ago 0 0 0 0
Preview
What is the difference between Opdivo and Keytruda? Official answer: Opdivo (nivolumab) and Keytruda (pembrolizumab) are two immunotherapy drugs used to treat various cancers. Both are...

Opdivo & Keytruda are both PD-1 inhibitor immunotherapies treating multiple cancers. They differ in dosing schedules, approved cancer types, and combination treatments. New under-skin formulations, Opdivo Qvantig & Keytruda Qlex, offer faster, convenient administration.

6 days ago 0 0 0 0
Advertisement
Preview
Demand Surge Leads to Shortages of Estrogen Patches - Drugs.com MedNews FRIDAY, April 10, 2026 Growing demand for estrogen patches to relieve menopause symptoms has led to shortages, leaving women searching multiple pharmacies or sw

Estrogen patch shortages could last 3 years as demand surges following the FDA lifting a safety warning on HRT last November. Patches are generics with thin profit margins, so manufacturers have little incentive to scale up, and new facilities take years to build. www.drugs.com/news/demand-...

1 week ago 0 0 0 0
Preview
There Are No Good Ways To Avoid Childhood Eczema But Many Treatment Options - Drugs.com MedNews THURSDAY, April 9, 2026 There s very little parents can do to prevent their kids from developing eczema, according to new guidelines from the American Academy o

New AAD guidelines confirm that special diets, probiotic supplements, and other common tactics won't prevent eczema in kids. Moisturizer offers some early protection. But if your child does develop it, there are many effective treatments available. #EczemaTreatments www.drugs.com/news/there-n...

1 week ago 1 0 0 0
Preview
The Flu Vaccine Can Lower Your Risk Of Heart Attack And Stroke — Even If You Wind Up Infected - Drugs.com MedNews WEDNESDAY, April 8, 2026 The influenza vaccine can significantly reduce the risk of a flu-related heart attack or stroke, even among folks who become infected a

New research: the flu vaccine can cut your heart attack and stroke risk in half, even if you still get sick. Flu-driven inflammation spikes cardiovascular risk sharply in the first week of infection. #FluShotStrokePrevention

1 week ago 1 0 0 0
Preview
Could a High-Dose Flu Shot Lower Your Alzheimer's Risk? - Drugs.com MedNews TUESDAY, April 7, 2026 A high-powered flu shot might help reduce seniors risk of Alzheimer s disease, a new study says.Seniors who got a high-dose flu vaccine h

A new study found seniors who got the high-dose flu vaccine had a 55% reduced risk of Alzheimer's, vs. 40% for the standard dose. The CDC already recommends it for adults 65+, but many doctors don't know it exists. Ask your doctor about it. #FluShotAlzheimersDisease www.drugs.com/news/could-f...

1 week ago 0 0 0 0
Preview
Over 3 Million Eye Drops Recalled Amid Sterility Concerns - Drugs.com MedNews MONDAY, April 6, 2026 More than 3 million bottles of over-the-counter eye drops are being recalled after officials raised concerns about the product s safety. T

The FDA has recalled 3 million+ bottles of OTC eye drops made by K.C. Pharmaceuticals over sterility concerns. Affected drops were sold at CVS, Walgreens, and Rite Aid. No injuries reported yet. Check the FDA website to see if yours are included. #EyeDropRecall www.drugs.com/news/over-3-...

1 week ago 0 0 0 0
Preview
Nerve Stimulation Therapy May Ease Fibromyalgia Pain, Fatigue - Drugs.com MedNews FRIDAY, April 3, 2026 In its first real-world trial, the nerve stimulation treatment called TENS appeared to reduce the pain and tiredness of fibromyalgia. The

A real-world study of 384 fibromyalgia patients found that TENS therapy, used two hours daily alongside physical therapy, reduced both pain and fatigue within 60 days. 80% found it helpful. #Fibromyalgia www.drugs.com/news/nerve-s...

2 weeks ago 2 2 0 0

Gemtesa and Myrbetriq treat overactive bladder by relaxing the bladder muscle via beta-3 receptors, reducing urgency and leakage. Both are approved for adults; Myrbetriq also covers certain children. They differ in side effects and drug interactions.

2 weeks ago 1 0 0 0
Preview
FDA Approves New Weight Loss Pill, Foundayo, in Record Time - Drugs.com MedNews THURSDAY, April 2, 2026 A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved through review

The FDA approved #Foundayo, a new daily weight loss pill from Eli Lilly, 294 days ahead of schedule. It's the fastest approval of a new drug type since 2002. It targets GLP-1 receptors, similar to injectable weight loss drugs. Side effects and serious risks apply. www.drugs.com/news/fda-app...

2 weeks ago 1 0 0 0
Preview
How do Rinvoq and Dupixent compare? Official answer: Rinvoq (upadacitinib) and Dupixent (dupilumab) are two prescription medications that target underlying inflammation in...

Rinvoq (upadacitinib) and Dupixent (dupilumab) both treat chronic immune-related inflammatory conditions but work differently and carry distinct safety profiles. Both hold multiple FDA approvals, with indications expanding as research has grown. #RinvoqVsDupixent

2 weeks ago 1 0 0 0
Advertisement
Preview
Antidepressant, Fluvoxamine, Might Help Long COVID Fatigue, Study Says - Drugs.com MedNews WEDNESDAY, April 1, 2026 A common antidepressant appears to help reduce fatigue in people living with long COVID, a new study says. Fluvoxamine a low-cost and w

A common antidepressant, fluvoxamine, significantly reduced long COVID fatigue within 2 to 3 months, a new study found, with a 99% probability it beat placebo. #FluvoxamineLongCovid www.drugs.com/news/antidep...

2 weeks ago 0 0 0 0
Preview
Benlysta Patient Tips: 7 things you should know Easy-to-read patient tips for benlysta covering how it works, benefits, risks, and best practices.

#Benlysta is a prescription injectable treating systemic lupus erythematosus and active lupus nephritis in adults and children aged 5 and older. It works by inhibiting B-cell survival in the immune system and is classed as a BLyS-specific inhibitor.

2 weeks ago 0 0 0 0
Preview
Folks With Clogged Arteries Benefit From Aggressively Lower Cholesterol Goal - Drugs.com MedNews TUESDAY, March 31, 2026 Aggressively lowering high cholesterol can cut the risk of heart attack or stroke by about a third among people with clogged arteries, a

New study: lowering LDL cholesterol to under 55 mg/dL cuts heart attack and stroke risk by 33% in people with clogged arteries, with no added safety concerns. Talk to your doctor about whether a lower cholesterol target is right for you. #CholesterolLowering www.drugs.com/news/folks-c...

2 weeks ago 1 0 0 0
Preview
How does Zepbound help with sleep apnea? Official answer: Zepbound (tirzepatide) helps improve obstructive sleep apnea (OSA) in adults with obesity by causing substantial weight...

#Zepbound (tirzepatide) is the first US prescription medicine approved for moderate to severe obstructive sleep apnea in adults with obesity. Significant weight loss reduces airway blockages, cutting breathing disruptions by up to 29 per hour in clinical studies.

2 weeks ago 1 0 0 0
Preview
Kratom Cases Surging In U.S. - Drugs.com MedNews MONDAY, March 30, 2026 Kratom is becoming an increasing health threat in the U.S., with hospitalizations and calls to poison centers skyrocketing over the past

#Kratom hospitalizations and poison center calls have each surged over 1,100% in the past decade, a new study finds. The herbal supplement is unregulated and increasingly sold in stronger forms across the U.S., raising public health concerns. www.drugs.com/news/kratom-...

2 weeks ago 0 0 0 0
Preview
What are 8 key Kesimpta side effects to watch out for? Official answer: Key Points Kesimpta (ofatumumab) is an injectable medication that may be used to treat relapsing forms of multiple...

#Kesimpta is a monthly injectable treatment for relapsing multiple sclerosis. Common side effects include respiratory infections, injection reactions, and headache. Serious allergic reactions and infections require immediate attention.

2 weeks ago 0 0 0 0
Preview
Eylea Patient Tips: 7 things you should know Easy-to-read patient tips for Eylea covering how it works, benefits, risks, and best practices.

#Eylea and Eylea HD contain aflibercept, a VEGF inhibitor injected into the eye to treat wet macular degeneration, diabetic retinopathy, and related retinal conditions. The eye is numbed beforehand. Common side effects include temporary bleeding, eye pain, and redness.

3 weeks ago 0 0 0 0
Preview
Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds - Drugs.com MedNews THURSDAY, March 26, 2026 Ritalin prescribed to children with ADHD might provide mental health benefits that extend far into adulthood, a new study suggests. Chi

New research in JAMA Psychiatry: kids prescribed Ritalin for ADHD may face a lower risk of schizophrenia and psychosis as adults. The protective effect only appears when treatment starts in childhood, not adolescence or later. www.drugs.com/news/ritalin...

3 weeks ago 1 0 0 0
Advertisement
Preview
What makes Auvelity different from other antidepressants? Official answer: Auvelity is a combination oral tablet for depression containing dextromethorphan and bupropion that works differently...

#Auvelity combines dextromethorphan and bupropion to treat depression by blocking overactive NMDA receptors triggered by high glutamate levels. Unlike traditional antidepressants, it acts faster and may be more effective, offering a different approach to treatment. www.drugs.com/medical-answ...

3 weeks ago 1 0 0 0
Preview
U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes - Drugs.com MedNews WEDNESDAY, March 25, 2026 Americans are trapped in a ruthless social media spin cycle of viral misinformation regarding science and medicine, with many actively

A new Harris Poll finds 75% of Americans share health & science articles based on headlines alone, fueling a #misinformation spiral that's eroding trust in medicine. 82% worry about their families because of it. We value science, but just need to read before we share. www.drugs.com/news/u-s-med...

3 weeks ago 0 0 0 0
Preview
Ibrance Patient Tips: 7 things you should know Easy-to-read patient tips for Ibrance covering how it works, benefits, risks, and best practices.

Ibrance (palbociclib) blocks enzymes driving cancer cell growth, treating advanced HR+/HER2- breast cancer. Taken for 21 of 28 days, it's combined with hormonal therapy. Side effects include fatigue, nausea, and low white blood cell counts. Regular monitoring required. www.drugs.com/tips/ibrance...

3 weeks ago 0 0 0 0
Preview
New Lyme Disease Vaccine Shows Strong Results in Trial - Drugs.com MedNews TUESDAY, March 24, 2026 A new vaccine meant to prevent Lyme disease may be one step closer to approval. Drugmaker Pfizer and French vaccine company Valneva said

A Lyme disease vaccine may be closer than ever. Pfizer and Valneva's LB6V showed 70%+ effectiveness in trials for ages 5+ with no safety concerns. Regulatory submissions are planned. No human Lyme vaccine currently exists. #LymeDiseaseVaccine www.drugs.com/news/new-lym...

3 weeks ago 9 7 0 1
Preview
FDA Approves Higher-Dose Wegovy To Help People Lose More Weight - Drugs.com MedNews MONDAY, March 23, 2026 A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher dose. The U.S. Fo

The FDA has approved Wegovy HD, a 7.2 mg version of the popular weight loss drug, up from 2.4 mg. Trial participants lost an average of ~47 lbs. It's expected to be available in U.S. pharmacies in April. Side effects are more common at the higher dose. #WegovyHighDose www.drugs.com/news/fda-app...

3 weeks ago 1 1 0 0